Erdmann F, Lortet-Tieulent J, Schuz J et al. International trends in the incidence of malignant melanoma 1953–2008—are recent generations at higher or lower risk? Int J Cancer. 2013;132:385 e400.
Whiteman DC, Green AC, Olsen CM. The growing burden of invasive melanoma: projections of incidence rates and numbers of new cases in six susceptible populations to 2031. J invest Dermatol. 2016;136:1161–71. DOI: 10.1016/j.jid.2016.01.035
Belgian Cancer Registry 2019, Les dix tumeurs les plus fréquentes par sexe, Belgique 2019. https://kankerregister.org/media/images/cijfersoverkanker/top102019_FR_orig.jpg. accessed 22 April 2022
Belgian Cancer Registry 2019, Cancer fact sheet melanoma, Belgium 2019. https://kankerregister.org/media/docs/CancerFactSheets/2019/Cancer_Fact_Sheet_Melanoma_2019.pdf. Accessed 22 April 2022.
Veronesi U, Cascinelli N, Bufalino R. Evaluation of the risk of multiple primaries in malignant cutaneous melanoma. Tumori. 1976;62:127–30. DOI: 10.1177/030089167606200114
Giles G, Staples M, McCredie M, Coates M. Multiple primary melanomas: an analysis of cancer registry data from Victoria and New South Wales. Melanoma Res. 1995;5:433–8. DOI: 10.1097/00008390-199512000-00007
Ariyan S, Poo WJ, Bolognia J, Buzaid A, Ariyan T. Multiple primary melanomas: data and significance. Plast Reconstr Surg. 1995;96:1384–9. DOI: 10.1097/00006534-199511000-00023
Savoia P, Quaglino P, Verrone A, Bernengo MG. Multiple primary melanomas: analysis of 49 cases. Melanoma Res. 1998;8:361–6. DOI: 10.1097/00008390-199808000-00010
Stam-Posthuma JJ, Van Duinen C, Scheffer E. Vink J, Bergman W. Multiple primary melanomas. J Am Acad Dermatol. 2001;44:22–7.
Doubrovsky A, Menzies SW. Enhanced survival in patients with multiple primary melanoma. Arch Dermatol. 2003;139:1013–8. DOI: 10.1001/archderm.139.8.1013
Ferrone C, Ben Porat L, Panageas K, et al. Clinicopathological features of and risk factors for multiple primary melanomas. JAMA. 2005;294:1647–54. DOI: 10.1001/jama.294.13.1647
Titus-Ernstoff L, Perry AE, Spencer SK, et al. Multiple Primary melanoma: two-year results from a population-based study. Arch Dermatol. 2006;142:433–8. DOI: 10.1001/archderm.142.4.433
Uliasz A, Lebwohl M. Patient education and regular surveillance results in earlier diagnosis of second primary melanoma. Int J Dermatol. 2007;46:575–7. DOI: 10.1111/j.1365-4632.2007.02704.x
Buljan M, Situm M, Bolanca Z, Zivkovic MV, Mihic LL. Multiple primary melanoma: epidemiological and prognostic implications; analysis of 36 cases. Collegium Antropologicum Avril. 2010;34(Supp 2):131–4.
Leiter U, Buetnner PG, Eigentler TK, et al. Hazard rates for recurrent and secondary cutaneous melanoma: an analysis of 33,384 patients in the German Central Malignant Melanoma Registry. J Am Acad Dermatol. 2012;66:37–45. DOI: 10.1016/j.jaad.2010.09.772
Moore MM, Geller AC, Warton EM, Schwalbe J, Asgari MM. Multiple primary melanomas among 16,570 patients with melanoma diagnosed at Kaiser Permanente Northern California, 1996 to 2011. J Am Acad Dermatol. 2015;73:630–6. DOI: 10.1016/j.jaad.2015.06.059
Menzies S, Barry R, Ormond P. Multiple primary melanoma: a single restropective review. Melanoma Res. 2017;27:638–40. DOI: 10.1097/CMR.0000000000000395
Schuurman MS, de Waal AC, Thijs EJM, Van Rossum MM, Kiemeney LALM, Aben KKH. Risk factors for second primary melanoma among Dutch patients with melanoma. Br J Dermatol. 2017;176:971–8. DOI: 10.1111/bjd.15024
Hwa C, Price LS, Belitskaya-Levy I, et al. Single versus multiple primary melanomas: old questions and new answers. Cancer. 2012;118:4184–92. DOI: 10.1002/cncr.27407
Vecchiato A, Pasquali S, Menin C, et al. Histopathological characteristics of subsequent melanomas in patients with multiple primary melanomas. J Eur Acad Dermatol Venereol. 2014;28:58–64. DOI: 10.1111/jdv.12055
El Sharouni MA, Witkamp AJ, Sigurdsson V, Van Diest PJ. Comparison of survival between patients with single versus multiple primary cutaneous melanomas. JAMA Dermatol. 2019;155:1049–56. DOI: 10.1001/jamadermatol.2019.1134
Michielin O, Van Akkooi ACJ, Ascierto PA, Dummer R, Keilholz U. Cutaneous melanoma: ESMO clinical practice guidelines for diagnosis treatment and follow up. Ann Oncol. 2019;30:1884–901. DOI: 10.1093/annonc/mdz411
Garbe C, Amaral T, Peris K, et al. European consensus-based interdisciplinary guideline for melanoma. Part 1: diagnostics – update 2019. Eur J Cancer. 2020;126:141–58.
Swetter SM, Tsao H, Bichakjian CK, et al. Guidelines of care for the management of primary cutaneous melanoma. J Am Acad Dermatol. 2019;80:208–50. DOI: 10.1016/j.jaad.2018.08.055
Keung EZ, Gershenwald JE. The eight edition American Joint Committee on Cancer (AJCC) melanoma staging system: implications for melanoma treatment and care. Expert Rev Anticancer Ther. 2018;18:775–84.
Youlden DR, Baade PD, Soyer HP, et al. Ten-year survival after multiple invasive melanoma is worse than after a single melanoma: a population-based study. J Invest Dermatol. 2016;136:2270–6. DOI: 10.1016/j.jid.2016.03.014
Pardo LM, van der Leest RJ, de Vries E, Soerjomataram I, Nijsten T, Hollestein LM. Comparing survival of patients with single or multiple primary melanoma in the Netherlands: 1994–2009. Br J Dermatol. 2017;176:531–3. DOI: 10.1111/bjd.14846
Peek G, Olsen CM, Baade P, et al. Survival in patients with multiple primary melanomas: systematic review and meta-analysis. J Am Acad Dermatol. 2020;83:1406–14. DOI: 10.1016/j.jaad.2020.03.076
